Dr. William Carlezon of Harvard University’s Program in Neuroscience will present a seminar titled “CREB and Kappa-Opioid Receptors in the Study and Treatment of Substance Abuse and Depressive Disorders” on Friday, April 27, at 12:05 p.m. in Wegner G-1.